Literature DB >> 21203970

Wld(S), Nmnats and axon degeneration--progress in the past two decades.

Yan Feng1, Tingting Yan, Zhigang He, Qiwei Zhai.   

Abstract

A chimeric protein called Wallerian degeneration slow (Wld(S)) was first discovered in a spontaneous mutant strain of mice that exhibited delayed Wallerian degeneration. This provides a useful tool in elucidating the mechanisms of axon degeneration. Over-expression of Wld(S) attenuates the axon degeneration that is associated with several neurodegenerative disease models, suggesting a new logic for developing a potential protective strategy. At molecular level, although Wld(S) is a fusion protein, the nicotinamide mononucleotide adenylyl transferase 1 (Nmnat1) is required and sufficient for the protective effects of Wld(S), indicating a critical role of NAD biosynthesis and perhaps energy metabolism in axon degeneration. These findings challenge the proposed model in which axon degeneration is operated by an active programmed process and thus may have important implication in understanding the mechanisms of neurodegeneration. In this review, we will summarize these recent findings and discuss their relevance to the mechanisms of axon degeneration.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 21203970      PMCID: PMC4875081          DOI: 10.1007/s13238-010-0021-2

Source DB:  PubMed          Journal:  Protein Cell        ISSN: 1674-800X            Impact factor:   14.870


  71 in total

1.  A novel ubiquitination factor, E4, is involved in multiubiquitin chain assembly.

Authors:  M Koegl; T Hoppe; S Schlenker; H D Ulrich; T U Mayer; S Jentsch
Journal:  Cell       Date:  1999-03-05       Impact factor: 41.582

Review 2.  Axonal self-destruction and neurodegeneration.

Authors:  Martin C Raff; Alan V Whitmore; John T Finn
Journal:  Science       Date:  2002-05-03       Impact factor: 47.728

3.  Differential effects of neurotrophic factors on motoneuron retrograde labeling in a murine model of motoneuron disease.

Authors:  Y Sagot; T Rossé; R Vejsada; D Perrelet; A C Kato
Journal:  J Neurosci       Date:  1998-02-01       Impact factor: 6.167

4.  Characterization of recombinant human nicotinamide mononucleotide adenylyl transferase (NMNAT), a nuclear enzyme essential for NAD synthesis.

Authors:  M Schweiger; K Hennig; F Lerner; M Niere; M Hirsch-Kauffmann; T Specht; C Weise; S L Oei; M Ziegler
Journal:  FEBS Lett       Date:  2001-03-09       Impact factor: 4.124

5.  The gene for slow Wallerian degeneration (Wld(s)) is also protective against vincristine neuropathy.

Authors:  M Wang; Y Wu; D G Culver; J D Glass
Journal:  Neurobiol Dis       Date:  2001-02       Impact factor: 5.996

6.  A rat model of slow Wallerian degeneration (WldS) with improved preservation of neuromuscular synapses.

Authors:  Robert Adalbert; Thomas H Gillingwater; Jane E Haley; Katherine Bridge; Bogdan Beirowski; Livia Berek; Diana Wagner; Daniela Grumme; Derek Thomson; Arzu Celik; Klaus Addicks; Richard R Ribchester; Michael P Coleman
Journal:  Eur J Neurosci       Date:  2005-01       Impact factor: 3.386

7.  The Drosophila cell corpse engulfment receptor Draper mediates glial clearance of severed axons.

Authors:  Jennifer M MacDonald; Margaret G Beach; Ermelinda Porpiglia; Amy E Sheehan; Ryan J Watts; Marc R Freeman
Journal:  Neuron       Date:  2006-06-15       Impact factor: 17.173

8.  Identification and characterization of a second NMN adenylyltransferase gene in Saccharomyces cerevisiae.

Authors:  Monica Emanuelli; Adolfo Amici; Francesco Carnevali; Francesca Pierella; Nadia Raffaelli; Giulio Magni
Journal:  Protein Expr Purif       Date:  2003-02       Impact factor: 1.650

9.  Absence of Wallerian Degeneration does not Hinder Regeneration in Peripheral Nerve.

Authors:  E R Lunn; V H Perry; M C Brown; H Rosen; S Gordon
Journal:  Eur J Neurosci       Date:  1989       Impact factor: 3.386

10.  Inhibiting axon degeneration and synapse loss attenuates apoptosis and disease progression in a mouse model of motoneuron disease.

Authors:  Anna Ferri; Joshua R Sanes; Michael P Coleman; Jeanette M Cunningham; Ann C Kato
Journal:  Curr Biol       Date:  2003-04-15       Impact factor: 10.834

View more
  17 in total

Review 1.  Axon degeneration in Parkinson's disease.

Authors:  Robert E Burke; Karen O'Malley
Journal:  Exp Neurol       Date:  2012-01-18       Impact factor: 5.330

2.  Chaperoning the synapse--NMNAT protects Bruchpilot from crashing.

Authors:  Elsa Lauwers; Patrik Verstreken
Journal:  EMBO Rep       Date:  2012-11-30       Impact factor: 8.807

Review 3.  The role of ubiquitin-mediated pathways in regulating synaptic development, axonal degeneration and regeneration: insights from fly and worm.

Authors:  Xiaolin Tian; Chunlai Wu
Journal:  J Physiol       Date:  2013-04-22       Impact factor: 5.182

4.  Regulation of axon guidance by compartmentalized nonsense-mediated mRNA decay.

Authors:  Dilek Colak; Sheng-Jian Ji; Bo T Porse; Samie R Jaffrey
Journal:  Cell       Date:  2013-06-06       Impact factor: 41.582

5.  Mutations in NMNAT1 cause Leber congenital amaurosis with early-onset severe macular and optic atrophy.

Authors:  Isabelle Perrault; Sylvain Hanein; Xavier Zanlonghi; Valérie Serre; Michael Nicouleau; Sabine Defoort-Delhemmes; Nathalie Delphin; Lucas Fares-Taie; Sylvie Gerber; Olivia Xerri; Catherine Edelson; Alice Goldenberg; Alice Duncombe; Gylène Le Meur; Christian Hamel; Eduardo Silva; Patrick Nitschke; Patrick Calvas; Arnold Munnich; Olivier Roche; Hélène Dollfus; Josseline Kaplan; Jean-Michel Rozet
Journal:  Nat Genet       Date:  2012-07-29       Impact factor: 38.330

6.  Mutations in NMNAT1 cause Leber congenital amaurosis and identify a new disease pathway for retinal degeneration.

Authors:  Robert K Koenekoop; Hui Wang; Jacek Majewski; Xia Wang; Irma Lopez; Huanan Ren; Yiyun Chen; Yumei Li; Gerald A Fishman; Mohammed Genead; Jeremy Schwartzentruber; Naimesh Solanki; Elias I Traboulsi; Jingliang Cheng; Clare V Logan; Martin McKibbin; Bruce E Hayward; David A Parry; Colin A Johnson; Mohammed Nageeb; James A Poulter; Moin D Mohamed; Hussain Jafri; Yasmin Rashid; Graham R Taylor; Vafa Keser; Graeme Mardon; Huidan Xu; Chris F Inglehearn; Qing Fu; Carmel Toomes; Rui Chen
Journal:  Nat Genet       Date:  2012-07-29       Impact factor: 38.330

7.  Protection of mouse retinal ganglion cell axons and soma from glaucomatous and ischemic injury by cytoplasmic overexpression of Nmnat1.

Authors:  Yanli Zhu; Lihong Zhang; Yo Sasaki; Jeffrey Milbrandt; Jeffrey M Gidday
Journal:  Invest Ophthalmol Vis Sci       Date:  2013-01-02       Impact factor: 4.799

Review 8.  NMNATs, evolutionarily conserved neuronal maintenance factors.

Authors:  Yousuf O Ali; David Li-Kroeger; Hugo J Bellen; R Grace Zhai; Hui-Chen Lu
Journal:  Trends Neurosci       Date:  2013-08-20       Impact factor: 13.837

9.  Retinal ganglion cell survival and axon regeneration in WldS transgenic rats after optic nerve crush and lens injury.

Authors:  Barbara Lorber; Alessia Tassoni; Natalie D Bull; Marilita M Moschos; Keith R Martin
Journal:  BMC Neurosci       Date:  2012-06-06       Impact factor: 3.288

10.  Nicotinamide mononucleotide adenylyltransferase 2 (Nmnat2) regulates axon integrity in the mouse embryo.

Authors:  Amy N Hicks; Diego Lorenzetti; Jonathan Gilley; Baisong Lu; Karl-Erik Andersson; Carol Miligan; Paul A Overbeek; Ronald Oppenheim; Colin E Bishop
Journal:  PLoS One       Date:  2012-10-17       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.